S&P 500   3,981.00 (-2.64%)
DOW   31,950.59 (-2.16%)
QQQ   297.74 (-2.75%)
AAPL   144.12 (-3.43%)
MSFT   258.75 (-3.02%)
FB   197.86 (-2.35%)
GOOGL   2,276.62 (-2.27%)
AMZN   2,193.04 (-4.95%)
TSLA   741.55 (-2.63%)
NVDA   176.70 (-2.79%)
BABA   89.96 (-2.21%)
NIO   16.50 (-0.78%)
AMD   100.98 (-1.45%)
CGC   5.82 (-1.19%)
MU   72.87 (-2.16%)
T   20.37 (-0.97%)
GE   75.81 (-0.77%)
F   13.03 (-3.70%)
DIS   105.95 (-2.48%)
AMC   13.54 (+4.96%)
PFE   50.80 (-1.05%)
PYPL   78.99 (-0.95%)
NFLX   184.63 (-3.11%)
S&P 500   3,981.00 (-2.64%)
DOW   31,950.59 (-2.16%)
QQQ   297.74 (-2.75%)
AAPL   144.12 (-3.43%)
MSFT   258.75 (-3.02%)
FB   197.86 (-2.35%)
GOOGL   2,276.62 (-2.27%)
AMZN   2,193.04 (-4.95%)
TSLA   741.55 (-2.63%)
NVDA   176.70 (-2.79%)
BABA   89.96 (-2.21%)
NIO   16.50 (-0.78%)
AMD   100.98 (-1.45%)
CGC   5.82 (-1.19%)
MU   72.87 (-2.16%)
T   20.37 (-0.97%)
GE   75.81 (-0.77%)
F   13.03 (-3.70%)
DIS   105.95 (-2.48%)
AMC   13.54 (+4.96%)
PFE   50.80 (-1.05%)
PYPL   78.99 (-0.95%)
NFLX   184.63 (-3.11%)
S&P 500   3,981.00 (-2.64%)
DOW   31,950.59 (-2.16%)
QQQ   297.74 (-2.75%)
AAPL   144.12 (-3.43%)
MSFT   258.75 (-3.02%)
FB   197.86 (-2.35%)
GOOGL   2,276.62 (-2.27%)
AMZN   2,193.04 (-4.95%)
TSLA   741.55 (-2.63%)
NVDA   176.70 (-2.79%)
BABA   89.96 (-2.21%)
NIO   16.50 (-0.78%)
AMD   100.98 (-1.45%)
CGC   5.82 (-1.19%)
MU   72.87 (-2.16%)
T   20.37 (-0.97%)
GE   75.81 (-0.77%)
F   13.03 (-3.70%)
DIS   105.95 (-2.48%)
AMC   13.54 (+4.96%)
PFE   50.80 (-1.05%)
PYPL   78.99 (-0.95%)
NFLX   184.63 (-3.11%)
S&P 500   3,981.00 (-2.64%)
DOW   31,950.59 (-2.16%)
QQQ   297.74 (-2.75%)
AAPL   144.12 (-3.43%)
MSFT   258.75 (-3.02%)
FB   197.86 (-2.35%)
GOOGL   2,276.62 (-2.27%)
AMZN   2,193.04 (-4.95%)
TSLA   741.55 (-2.63%)
NVDA   176.70 (-2.79%)
BABA   89.96 (-2.21%)
NIO   16.50 (-0.78%)
AMD   100.98 (-1.45%)
CGC   5.82 (-1.19%)
MU   72.87 (-2.16%)
T   20.37 (-0.97%)
GE   75.81 (-0.77%)
F   13.03 (-3.70%)
DIS   105.95 (-2.48%)
AMC   13.54 (+4.96%)
PFE   50.80 (-1.05%)
PYPL   78.99 (-0.95%)
NFLX   184.63 (-3.11%)
LON:VLG

Venture Life Group (VLG) Share Forecast, Price & News

GBX 33.05
-2.45 (-6.90%)
(As of 05/18/2022 04:18 PM ET)
Add
Compare
Today's Range
32.02
35.30
50-Day Range
33.80
40.70
52-Week Range
27
105
Volume
722,275 shs
Average Volume
216,845 shs
Market Capitalization
£41.59 million
P/E Ratio
110.17
Dividend Yield
0.09%
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive VLG News and Ratings via Email

Sign-up to receive the latest news and ratings for Venture Life Group and its competitors with MarketBeat's FREE daily newsletter.

Venture Life Group logo

About Venture Life Group

Venture Life Group plc develops and commercializes oral care products, food supplements, medical devices, dermo-cosmetics, and topical products for the ageing population in the United Kingdom, Netherlands, China, Germany, Italy, Switzerland, rest of Europe, and internationally. It operates through Venture Life Brands and Customer Brands segments. The company offers neurology products, including NeuroAge, NeuroAge Sleep, and NeuroAge NRG food supplements to enhance mental alertness, cognitive function, and mental performance in ageing brain; and Original Bioscalin to treat and prevent hair loss, hair thinning, and baldness. It also provides Fungal Nail Solution, which helps to treat and prevent fungal infections; and Fungal Nail Cleanser for the hygiene of hands and feet prone to fungal nail infections under the Myco Clear brand name. In addition, the company offers UltraDEX Original and UltraDEX Sensitive for bad breath; Dently Dual Action, a mouthwash, which lifts and removes plaque and bacteria from the teeth and mouth; and Procto-eze for anal irritation, including haemorrhoids condition. Further, it provides women healthcare products comprising vonalei bacterial vaginosis, a refreshing gel; vonalei Vaginal Atrophy, a vaginal cream; vonalei candidiasis, a soothing cream-gel for thrush; and vonalei intimate cleansing foam. Additionally, it offers Cleansing Foam, Cleansing Cream, and Serum under the Rosa calma brand name; and skincare ranges to hydrate, nourish, and recondition the skin, as well as to prevent the lines and wrinkles under the Lubatti Classic and the Lubatti Anti-age brand names. The company sells its products through a network of international partners, retail pharmacies, as well as grocery multiple retailers. Venture Life Group plc was incorporated in 2005 and is headquartered in Bracknell, the United Kingdom.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
119
Year Founded
N/A

Sales & Book Value

Annual Sales
£27.05 million
Cash Flow
GBX 5.95 per share
Book Value
GBX 56.10 per share

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
£41.59 million
Optionable
Not Optionable

MarketRank

Overall MarketRank

1.08 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -













Venture Life Group (LON:VLG) Frequently Asked Questions

Who are Venture Life Group's key executives?
Venture Life Group's management team includes the following people:
  • Mr. Jeremy Anthony Philip Randall, Co-Founder, CEO & Exec. Director (Age 57, Pay $440.39k)
  • Ms. Sharon Mary Daly, Co-Founder, Chief Commercial Officer & Exec. Director (Age 47, Pay $348.06k)
  • Mr. Lodovico Gianluca Braguti, Chief Manufacturing Officer & Exec. Director
  • Mr. Daniel James Wells, CFO & Director (Age 35)
  • Mr. Domenico Barbaro, Head of Procurement
  • Mr. Giuseppe Gioffrè, Group Financial Controller & Company Sec.
What other stocks do shareholders of Venture Life Group own?
What is Venture Life Group's stock symbol?

Venture Life Group trades on the London Stock Exchange (LON) under the ticker symbol "VLG."

How do I buy shares of Venture Life Group?

Shares of VLG and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Venture Life Group's stock price today?

One share of VLG stock can currently be purchased for approximately GBX 33.05.

How much money does Venture Life Group make?

Venture Life Group has a market capitalization of £41.59 million and generates £27.05 million in revenue each year.

How many employees does Venture Life Group have?

Venture Life Group employs 119 workers across the globe.

What is Venture Life Group's official website?

The official website for Venture Life Group is www.venture-life.com.

How can I contact Venture Life Group?

Venture Life Group's mailing address is Venture House 2 Arlington Square, Downshire Way, BRACKNELL, RG12 1WA, United Kingdom. The company can be reached via phone at +44-1344-742870.

This page was last updated on 5/18/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.